Low-level arsenite causes accumulation of ubiquitinated proteins in rabbit renal cortical slices and HEK293 cells

Toxicology and Applied Pharmacology

Volumn 186, Issue 2, 2003, Pages 101-109

  Kirkpatrick, D S ^a   Dale, K V ^a   Catania, J M ^a   Gandolfi, A J ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b Division of Plant Pathology and Microbiology   (United States)

Author keywords

Arsenite; As(III); HEK293 cells; Proteasome; Rabbit renal cortical slices; Ubiquitin

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; PROTEASOME; UBIQUITIN;

ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONCENTRATION (PARAMETERS); CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; ENVIRONMENTAL EXPOSURE; FIBROBLAST; HOMEOSTASIS; HUMAN; HUMAN TISSUE; KIDNEY CORTEX; KIDNEY SLICE; MOLECULAR WEIGHT; NONHUMAN; RABBIT;

ORYCTOLAGUS CUNICULUS;

EID: 0037438021     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(02)00019-4     Document Type: Article

References (37)

1. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16:1997;3797-3804.
2. Bolton A.E. Comparative methods for the radiolabeling of peptides. Methods Enzymol. 124:1986;18-29.
3. Breitschopf K., Zeiher A.M., Dimmeler S. Ubiquitin-mediated degradation of the proapoptotic active form of bid a functional consequence on apoptosis induction . J. Biol. Chem. 275:2000;21648-21652.
4. Chen F., Zhang Z., Bower J., Lu Y., Leonard S.S., Ding M., Castranova V., Piwnica-Worms H., Shi X. Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA. 99:2002;1990-1995.
5. Chen F., Zhang Z., Leonard S.S., Shi X. Contrasting roles of NF-kappaB and JNK in arsenite-induced p53-independent expression of GADD45alpha. Oncogene. 20:2001;3585-3589.
6. Fujimuro M., Sawada H., Yokosawa H. Dynamics of ubiquitin conjugation during heat-shock response revealed by using a monoclonal antibody specific to multi-ubiquitin chains. Eur. J. Biochem. 249:1997;427-433.
7. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway destruction for the sake of construction . Physiol. Rev. 82:2001;373-428.
8. Gross-Mesilaty S., Reinstein E., Bercovich B., Tobias K.E., Schwartz A.L., Kahana C., Ciechanover A. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc. Natl. Acad. Sci. USA. 95:1998;8058-8063.
9. Hamadeh H.K., Vargas M., Lee E., Menzel D.B. Arsenic disrupts cellular levels of p53 and mdm2 a potential mechanism of carcinogenesis . Biochem. Biophys. Res. Commun. 263:1999;446-449.
10. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67:1998;425-479.
11. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA. 95:1998;7987-7992.
12. Kitchen K.T. Recent advances in arsenic carcinogenesis modes of action, animal model systems, and methylated arsenic metabolites . Toxicol. Appl. Pharmacol. 172:2001;249-261.
13. Klemperer N.S., Pickart C.M. Arsenite inhibits two steps in the ubiquitin-dependent proteolytic pathway. J. Biol. Chem. 264:1989;19245-19252.
14. Lallemand-Breitenbach V., Zhu J., Puvion F., Koken M., Honore N., Doubeikovsky A., Duprez E., Pandolfi P.P., Puvion E., Freemont P., de The H. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193:2001;1361-1371.
15. Lee D.H., Goldberg A.L. Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J. Biol. Chem. 271:1996;27280-27284.
16. Lee H.W., Smith L., Pettit G.R., Vinitsky A., Smith J.B. Ubiquitination of protein kinase C-alpha and degradation by the proteasome. J. Biol. Chem. 271:1996;20973-20976.
17. Li B., Dou Q.P. Bax degradation by the ubiquitin/proteasome-dependent pathway involvement in tumor survival and progression . Proc. Natl. Acad. Sci. USA. 97:2000;3850-3855.
18. Loveland B.E., Johns T.G., Mackay I.R., Vaillant F., Wang Z.X., Hertzog P.J. Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem. Int. 27:1992;501-510.
19. Mimnaugh E.G., Chen H.Y., Davie J.R., Celis J.E., Neckers L. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers effects on replication, transcription, translation, and the cellular stress response . Biochemistry. 36:1997;14418-14429.
20. Muller S., Matunis M.J., Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17:1998;61-70.
21. Arsenic in Drinking Water. 1999;National Academy Press, Washington, DC.
22. Arsenic in Drinking Water 2001 update . 2001;National Academy Press, Washington, DC.
23. Parrish A.R., Zheng X.H., Turney K.D., Younis H.S., Gandolfi A.J. Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices. Toxicol. Sci. 50:1999;98-105.
24. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:2001;503-533.
25. Pickart C.M. Ubiquitin enters the new millennium. Mol. Cell. 8:2001;499-504.
26. Rahman M., Tondel M., Ahmad S.A., Chowdhury I.A., Faruquee M.H., Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension. 33:1999;74-78.
27. Reidlinger J., Pike A.M., Savory P.J., Murray R.J., Rivett J. Catalytic properties of 26S and 20S proteasomes and radiolabeling of MB1, LMP7, and C7 subunits associated with trypsin-like and chymotrypsin-like activities. J. Biol. Chem. 272:1997;24899-24905.
28. Roussel R.R., Barchowsky A. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation. Arch. Biochem. Biophys. 377:2000;204-212.
29. Ruegg C.E., Gandolfi A.J., Nagle R.B., Krumdieck C.L., Brendel K. Preparation of positional renal slices for study of cell-specific toxicity. J. Pharmacol. Methods. 17:1987;111-123.
30. Shang F., Gong X., Taylor A. Activity of ubiquitin-dependent pathway in response to oxidative stress ubiquitin-activating enzyme is transiently up-regulated . J. Biol. Chem. 272:1997;23086-23093.
31. Shang F., Taylor A. Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. Biochem. J. 307:1995;297-303.
32. Shinohara K., Tomioka M., Nakano H., Tone S., Ito H., Kawashima S. Apoptosis induction resulting from proteasome inhibition. Biochem. J. 317:1996;385-388.
33. Treier M., Staszewski L.M., Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell. 78:1994;787-798.
34. Tsirigotis M., Zhang M., Chiu R.K., Wouters B.G., Gray D.A. Sensitivity of mammalian cells expressing mutant ubiquitin to protein-damaging agents. J. Biol. Chem. 276:2001;46073-46078.
35. Vogt B.L., Rossman T.G. Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts a possible mechanism for arsenite's comutagenicity . Mutat. Res. 478:2001;159-168.
36. Waxman L., Fagan J.M., Goldberg A.L. Demonstration of two distinct high molecular weight proteases in rabbit reticulocytes, one of which degrades ubiquitin conjugates. J. Biol. Chem. 262:1987;2451-2457.
37. Yih L.H., Peck K., Lee T.C. Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis. 23:2002;867-876.